The demand for the anti-viral drug “Remdesivir” has increased with a surge in COVID-19 cases. Besides the restrictions on its inter-state distribution have led to a war of attrition between the Maharashtra leaders and the Centre.
The Union Government has allowed the Mumbai-based Haffkine Bio-Pharmaceutical Corporation Limited to produce “Covaxin” following technology transfer from the Hyderabad-based Bharat Biotech Corporation. The decision is expected to give a boost to vaccine production.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.